Showing results (101-110 of 219) with videos related to

Sort By:
Pageof 22
Bulletin Du Cancer|March 1, 1995
[Combination of mitoxantrone-vinorelbine as first-line chemotherapy for metastatic breast carcinoma]J M Ferrero, X Pivot, M Namer, et al.
Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|July 7, 2000
[The importance of IgG auto-antibodies, anti-collagen type II specific in Menière's disease and progressive hearing loss]J C Muiño, R Carreras, M A Ocampo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-upJ M Ferrero, A Ramaioli, R Largillier, et al.
Revista De Neurologia|March 1, 1995
[Neuromuscular gait disorders in pediatric age]B Martínez Menéndez, R Simón de las Heras, G Orejón de Luna, et al.
Zootaxa|July 28, 2015
Distribution of Sipuncula in the Gulf of Valencia and Cape Nao (western Mediterranean)L M Ferrero-Vicente, J A De-La-Ossa-Carretero, Y Del-Pilar-Ruso, et al.
Gastroenterologia Y Hepatologia|April 7, 2005
[Acalculous cholecystitis: an uncommon form of presentation of Q fever]L González Delgado, G López Larramona, S Santolaria Piedrafita, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]A Chassevent, M L Jourdan, M Ferrero-Poüs, et al.
The Journal of Physiology|August 1, 2025
Mathematical model of the zebrafish ventricular cardiomyocyte action potential and calcium transientLudovica Cestariolo, Zachary D Long, Arie O Verkerk, et al.
Oncology|April 18, 2008
Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapyR Largillier, B Valenza, J-M Ferrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)A Awada, I N Bondarenko, J Bonneterre, et al.
Pageof 22